文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

体积而非转移灶数目:澳大利亚视角下伽玛刀放射外科治疗颅内病灶的管理

Volume not number of metastases: Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective.
PubMed 文献 · Radiother Oncol · 2019-01-14

澳大利亚首个伽玛刀放射外科中心前瞻性纳入2010年8月至2017年7月治疗的180例不同原发灶颅内转移患者,全组中位生存9.2个月,2年总生存率20.7%,总颅内肿瘤体积与生存相关,治疗可行且有效,与国际经验一致。

要点

  • 全组180例颅内转移患者中位生存9.2个月,2年总生存率20.7%。
  • 肿瘤体积<3.2 cm3者中位生存11.4个月,体积>9.1 cm3者5.16个月。
  • 颅内转移灶数目较多时,总颅内肿瘤体积对预后预测可能更有意义。

核心结论

  • 澳大利亚首个伽玛刀放射外科中心的结果显示该治疗可行且有效,与国际经验一致。
  • 对于颅内转移灶数目较多的患者,总颅内肿瘤体积对预后预测可能更有意义。
  • 生存率按组织学来源似乎存在差异,这可能与某些肿瘤可同时获得全身免疫治疗有关。

研究设计与样本

  • 前瞻性收集的队列研究,纳入2010年8月至2017年7月在澳大利亚首个伽玛刀放射外科中心治疗的180例不同原发灶颅内转移患者。
  • 生存分析采用Kaplan-Meier法,多因素分析采用Cox回归。

主要发现

  • 目前141例患者(78.3%)已死于该疾病。
  • 全组中位生存9.2个月,2年总生存率20.7%。
  • 中位生存随肿瘤负荷体积不同而存在差异:体积<3.2 cm3者为11.4个月,体积>9.1 cm3者为5.16个月。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To assess the response of the first cohort of patients treated with Gamma Knife radiosurgery in Australia. MATERIALS AND METHODS: A prospectively collected cohort of 180 patients with intracranial metastases from different primaries was treated between August 2010 and July 2017. Survival was calculated using the Kaplan-Meier's method. Cox regression was used for multivariate analysis. RESULTS: Currently 141 patients (78.3%) have died of their disease. The median survival for the group as a whole was 9.2 months, with observed differences resulting from the volume of tumor burden (11.4 months for volumes <3.2 cm3 to 5.16 months for volume >9.1 cm3). Overall 2-year survival was 20.7%. CONCLUSION: Results from the first Gamma Knife radiosurgery center in Australia showed that the treatment is feasible and effective, consistent with the international experience. For patients with larger numbers of intracranial metastases, the total volume of the intracranial burden may be of more significance in predicting outcomes. While there appeared to be a difference in survival by histologic origin, this could be related to concurrent systemic immunotherapy available for certain tumors.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Izard MA, Moutrie V, Rogers JM, et al. Volume not number of metastases: Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective. Radiother Oncol. 2019. PMID: 30935580. doi:10.1016/j.radonc.2018.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。